Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Associate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.

The British Heart Foundation has awarded a Senior Clinical Research Fellowship to Associate Professor Neil Herring to support his group's work exploring the role of Neuropeptide-Y (NPY) during heart attacks and heart failure. Prof Herring has also been awarded a BHF Project grant as a Co-Principal Investigator with Professor Kim Dora in the Department of Pharmacology to explore the mechanisms by which NPY acts on the heart's small blood vessels during a heart attack. 

A heart attack is caused when the blood supply to the heart becomes blocked. Many people still die from this condition owing to life-threatening heart rhythms and/or heart failure, known as a weakened heart. After 50 years of research, beta-blockers are the only drugs that prolong life after a heart attack by preventing dangerous heart rhythms. These drugs target norepinephrine, a chemical that can trigger dangerous heart rhythms when the heart is damaged. Norepinephrine is a type of “neurotransmitter” - chemicals released by a specific group of stimulated nerves. 

Through two recent papers in the European Heart Journal and a paper in JAMA Cardiology, the Herring Lab have discovered that the same group of nerves also release a neurotransmitter called neuropeptide-Y (NPY), and that levels of NPY within the heart are very high following a heart attack and during heart failure. They have shown that NPY can trigger dangerous heart rhythms and worsen heart failure by further restricting the heart’s blood supply.

The aims of these new grants are three-fold: to discover whether standard blood samples taken from veins to measure NPY can help doctors identify patients at highest risk of death, to better understand the role that NPY plays in controlling the heart and vasculature through the disease process, and to test the impact of potential drugs that combat its actions.

BHF Senior Clinical Research Fellowships are designed to provide career opportunities in an established research institutions in the UK for outstanding Consultant Clinician Scientists with a track record of internationally competitive research who are expected to reach Chair level within 10 years. More information can be found on the BHF's What we fund webpages.

related news stories from the Herring Group

New approach to reducing damage after a heart attack

Biomarker predicts which patients with heart failure have a higher risk of dying

New target identified to help prevent dangerous heart rhythms after heart attack

 

Similar stories

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.

Joaquim Vieira brings heart regeneration research to the public at Pint of Science

Pint of Science is the world’s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

RDM researchers awarded £2million MRC grant

Researchers at the Cardiovascular Clinical Research Facility (CCRF) have won a five year MRC funding programme to help understand how high blood pressure (hypertension) during pregnancy affects the heart, brain and blood vessels throughout the life of women, as well as the children born after such a pregnancy.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.